HSA
- Status: likely_approved
🇸🇬 Molecule 129 in Singapore
Molecule 129 (TAGRAXOFUSP) regulatory status in Singapore.
Marketing authorisations
HSA
- Status: likely_approved
Molecule 129 in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Singapore
Frequently asked questions
Is Molecule 129 approved in Singapore?
Yes. HSA has authorised it; HSA has authorised it.
Who is the marketing authorisation holder for Molecule 129 in Singapore?
Stemline Therapeeutics Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.